We also analyzed the impact of gemcitabine treatment on the expression of several tumor-promoting genes-TPGs (IL8, IL6, CD44 and CD133) as well as CD95L in experimental tumors derived from the PancTuI-luc cell line with two different settings of treatment (palliative and adjuvant). This evidence concerns the gene CD44 and neoplasm.